Available Assessments

Adverse Childhood Experience (ACE) #

This assessment is administered once upon intake to determine how many adverse childhood experiences occurred during the patient’s life. Knowing the patients ACE score enables the providers to more quickly identify underlying trauma that may be perpetuating the persons substance use disorder (SUD). The ACE assessment provides validated, objective data, reducing clinical subjectivity and guides both care and care management.

Balance Assessment #

This weekly self-reported assessment is a 5 point scale that is based off of the dimensions of ASAM. It was designed to more accurately determine where a patient currently feels they are on the continuum. The scale measures cravings, physical health and wellness, mental and emotional health, relationship to relapse and recovery resources.

GAD-7 #

The 7-item Generalized Anxiety Disorder Scale (GAD-7) is a self-report scale used to measure GAD symptoms. This assessment is administered every 2 weeks to determine the patient’s levels of GAD. GAD is one of the most common mental disorders and is highly correlated with substance use disorder (SUD). Knowing the patients levels of anxiety enables the providers to create care plans and intervention strategies that will help to reduce anxiety and prevent relapse. The GAD-7 is a valid and efficient tool for screening for GAD and assessing its severity in clinical practice and research.

General Self Efficacy (GSE) #

The General Self-Efficacy Scale is a 10-item psychometric scale that is designed to assess optimistic self-beliefs to cope with a variety of difficult demands in life. In contrast to other scales that were designed to assess optimism, this one explicitly refers to personal agency, i.e., the belief that one’s actions are responsible for successful outcomes.

Holistic Hexagon #

This assessment is a quality of life scaling exercise that is administered weekly to determine where the patient is scoring in 6 categories that have been correlated with improved quality of life and overall well- being. The categories are as follows: Family, Friends, Recreation, Mental Health, Physical Health and Occupation. Quality of life (QoL) is increasingly recognized as central to recovery in patients with substance use disorders (SUD).

PHQ9 #

Patient Health Questionnaire (PHQ-9) provides clinicians with concise, self-administered tools for assessing depression. As depression is highly correlated with substance use disorder, diagnosing it quickly will enable providers to create treatment and management plans that will help to reduce symptoms. PHQ9s are administered every other week.

Perceived Stress Scale (PSS) #

This assessment is administered every 2 weeks to determine the patient’s stress levels. Stress is a precursor for depression, anxiety and substance use disorder. Knowing the patient’s levels of stress enables the providers to create care plans and intervention strategies that will help to reduce stress and prevent relapse. PPS items evaluate the degree to which individuals believe their life has been unpredictable, uncontrollable, and overloaded during the previous two weeks.

Readiness to Change #

The readiness to changes assessment is used to determine how ready the patient is to change the behaviors related to substance use disorder (SUD). Based on the transtheoretical model of behavior change, it assesses an individual’s readiness to act on a new healthier behavior and informs the provider on how to best guide the change. Readiness to Change assessments are administered every other week.

Recovery Capital Scale #

The recovery capital scale is a measure of the intrinsic and extrinsic resources a recovering individual can draw upon to recover from substance use disorder. The scale measures four components to recovery. This assessment is administered 1 week prior to discharge to determine what current recovery resources the patient has and to assist case managers to more properly assign aftercare recommendations and prevent relapse.

Stroop test #

The Stroop Color and Word Test (SCWT) is a neuropsychological test extensively used to assess the ability to inhibit cognitive interference that occurs when the processing of a specific stimulus feature impedes the simultaneous processing of a second stimulus attribute, well-known as the Stroop Effect.

Beck Depression Inventory (BDI) #

The Beck Depression Inventory (BDI) is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression.

Brief Substance Craving Scale #

Measures intensity and frequency of cravings for primary drugs of choice.